P1271: THE IMPACT OF CYTOMEGALOVIRUS-SPECIFIC T CELLS USAGE AS ADOPTIVE THERAPY IN PATIENTS WITH PT-CY AND TCR ΑΒ+/CD19+ CELLS DEPLETION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

• Anna Dmitrova,
• Mikhail Drokov,
• Tatiana Tupoleva,
• Dmitriy Tikhomirov,
• Grigoriy Efimov,
• Apollinariya Bogolyubova,
• Alexandra Maleeva,
• Murad Vagida,
• Zalina Fidarova,
• Evgeniy Zvonkov,
• Larisa Kuzmina,
• Elena Parovichnikova

Affiliations

Anna Dmitrova

1 National Research Center for Hematology, Bone marrow transplantation department, Moscow, Russia

Mikhail Drokov

1 National Research Center for Hematology, Bone marrow transplantation department, Moscow, Russia

Tatiana Tupoleva

2 National Research Center for Hematology, Department of Virology, Moscow, Russia

Dmitriy Tikhomirov

2 National Research Center for Hematology, Department of Virology, Moscow, Russia

Grigoriy Efimov

3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia

Apollinariya Bogolyubova

3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia

Alexandra Maleeva

3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia

Murad Vagida

3 National Research Center for Hematology, Laboratory of transplantation immunology, Moscow, Russia

Zalina Fidarova

4 National Research Center for Hematology, Department of Hematology and Hemoblastosis Chemotherapy, Moscow, Russia

Evgeniy Zvonkov

5 National Research Center for Hematology, Department of lymphoproliferative disorders, Moscow, Russia

Larisa Kuzmina

6 National Research Center for Hematology, Bone marrow transplantation department, Moscow, Russia

Elena Parovichnikova

7 National Research Center for Hematology, Moscow, Russia